There is no known cure for Crohn's disease (CD), but a better understanding of the evidence
base of both established treatments (such as enteral nutrition, corticosteroids, 5 …

This paper in the series from the World Congress of Gastroenterology addresses the safety
and immunogenicity of biological therapy. The safety profile in randomized controlled …

Children and adolescents with Crohn's disease (CD) present often with a more complicated
disease course compared to adult patients. In addition, the potential impact of CD on growth …

The advent of biological therapy has revolutionized inflammatory bowel disease (IBD) care.
Nonetheless, not all patients require biological therapy. Selection of patients depends on …

We report the results of a survey of the membership of the North American Society for
Pediatric Gastroenterology and Nutrition designed to determine pediatric …

The physician treating children with inflammatory bowel disease is confronted with a number
of specific problems, one of them being the lack of randomized, controlled drug trials in …

We present the case of a 28 year old lady with refractory Crohn's Disease treated with
infliximab throughout her pregnancy. Her baby was born healthy and received a Bacillus …

Inflammatory bowel disease (IBD) includes Crohn disease (CD) and ulcerative colitis (UC),
and is often diagnosed in late childhood and early adulthood. IBD is thought to develop as a …

Objectives Treatment options for patients with Crohn disease (CD) have expanded, but the
use of some of these options in pediatric patients remains controversial. The authors …

Objective: To systematically review the evidence base for the medical (pharmaceutical and
nutritional) treatment of paediatric inflammatory bowel disease. Methods: Key clinical …